california dmhc glp-1 coverage exclusion allowed has ended adult Medi-Cal for popular weight loss medications, leaving thousands of patients worried about losing treatment that helped control diabetes, prevent disease and change their lives. Doctors warn Ozempic will no longer be

2018 Mar 6;8(3):e020167

Phenolic compounds exhibit dual functionality, inhibiting lipoprotein oxidation and suppressing NF-B-mediated inflammation

How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context for oxidative stress predisposition through variants affecting metabolic resilience and antioxidant pathway efficiency

In 2023, semaglutide was the best-selling drug in the United States with nearly $14 billion in sales.1 There are an estimated 100 million obese adults in America, and an additional 37 million who may also be eligible to use medications like GLP-1s to manage chronic conditions

Dietary L-serine confers a competitive fitness advantage to Enterobacteriaceae in the inflamed gut

The most effective treatments break the inflammation cycle instead of just masking symptoms